chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Rash
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 735801), concerns a 71-year-old, elderly, female patient. The patient was allergic to sulfa, penicillin (PCN) and cephalosporins. The patient's current conditions included hypertension, degenerative disc/joint disease, and polyarthritis. The patient had no other current illness. The patient's concomitant medications include metoprolol, HCTZ, lisinopril, gabapentin, tramadol, MOBIC, PEPCID AC, ASA, fluticasone, TYLENOL PM, CENTRUM SILVER, CITRACAL calcium plus vitamin D, Fish Oil, TYLENOL extra strength for an unknown indication. On 22-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179523) and PNEUMOVAX (dose: 1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: as reported N030111). On 23-Jan-2018, one day after vaccination, the patient experienced painful arm, swollen with a rash from hand's width above the elbow up and over the shoulder (as reported). Subsequently, the patient was exhausted, had chills, body muscle weakness for 5 days. It was reported that, the patient was not seen in clinic. On an unknown date, the patient had recovered from all the events. The reporter assessed this case as non-serious. Non-significant case correction was received with IRD 07-Apr-2018: The misspelling was corrected in the case comment. No changes were done in narrative.
Age: 76.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Pain in extremity
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 735904), concerns a 76-year-old elderly female patient. The patient's medical history and concomitant medications were not reported. On 28-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178903). On 29-Dec-2017, one day after vaccination, the patient experienced very sore arm and sought medical treatment. At the time of this report, the outcome of the event was unknown. The reporter assessed the case as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Erythema, Rash pruritic
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736007), concerns a 76-year-old, elderly, female patient. The patient had no medical history and no known allergies. The concomitant medications included AUGMENTIN, ATROVENT, PROAIR, VIRTUSSIN (since an unspecified date). On 24-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179303 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product PREVNAR 13 (route of administration: intramuscular, anatomical location: right arm, batch number: S92740, dose and expiry date: not reported). On 25-Jan-2018, after 1 day of vaccination, the patient experienced mild rash at 5 inches below the injection site on right arm which lasted after 6 days. The patient stated that it was itchy at first but not now. There is also small patch of redness of the skin. The lab tests were not reported. At the time of the report, the outcome of the event (rash pruritic) was recovered and the outcome of the event (erythema) was unknown. The reporter assessed this case as non-serious. Non-significant case correction received 07-Apr-2018: Anatomical location of the event (right arm) was added in the narrative. Narrative was amended accordingly.
Age: 76.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736007), concerns a 76-year-old, elderly, female patient. The patient had no medical history and no known allergies. The concomitant medications included AUGMENTIN, ATROVENT, PROAIR, VIRTUSSIN (since an unspecified date). On 24-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179303 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product PREVNAR 13 (route of administration: intramuscular, anatomical location: right arm, batch number: S92740, dose and expiry date: not reported). On 25-Jan-2018, after 1 day of vaccination, the patient experienced mild rash at 5 inches below the injection site on right arm which lasted after 6 days. The patient stated that it was itchy at first but not now. There is also small patch of redness of the skin. The lab tests were not reported. At the time of the report, the outcome of the event (rash pruritic) was recovered and the outcome of the event (erythema) was unknown. The reporter assessed this case as non-serious. Non-significant case correction received 07-Apr-2018: Anatomical location of the event (right arm) was added in the narrative. Narrative was amended accordingly.
Age: 76.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Back pain, Chest pain, Eye irritation, Fatigue, Headache
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736209), concerns a 76-year-old, elderly female patient. The patient's current conditions included high blood pressure, high cholesterol and had no other current illness. The patient was allergic to unspecified antibiotics, cholesterol medications, pain medications, over the counter medications such as TYLENOL, ADVIL, BENADRYL, cough syrups. The concomitant medications included SYNTHROID, atenolol and CRESTOR for unknown indications. The patient had no lab data. On 31-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). On 02-Feb-2018, after 2 days of vaccination, the patient developed a low-grade fever of temperature varying from 97.5 to 97.8. On the same day, the patient also experienced burning, aching pain in arm that spread to back between shoulder blades, left upper arm and across chest. The patient experienced fatigue, burning eyes, headache. The patient slept on chair because the pain did not allow to lie down. The pain was unbearable, hard to explain, burned, aches and hurt. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Pain in extremity, Pyrexia, Sleep disorder
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736209), concerns a 76-year-old, elderly female patient. The patient's current conditions included high blood pressure, high cholesterol and had no other current illness. The patient was allergic to unspecified antibiotics, cholesterol medications, pain medications, over the counter medications such as TYLENOL, ADVIL, BENADRYL, cough syrups. The concomitant medications included SYNTHROID, atenolol and CRESTOR for unknown indications. The patient had no lab data. On 31-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). On 02-Feb-2018, after 2 days of vaccination, the patient developed a low-grade fever of temperature varying from 97.5 to 97.8. On the same day, the patient also experienced burning, aching pain in arm that spread to back between shoulder blades, left upper arm and across chest. The patient experienced fatigue, burning eyes, headache. The patient slept on chair because the pain did not allow to lie down. The pain was unbearable, hard to explain, burned, aches and hurt. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Eye irritation, Fatigue, Headache, Injection site pain, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736209), concerns a 76-year-old, elderly female patient. The patient's current conditions included high blood pressure, high cholesterol and had no other current illness. The patient was allergic to unspecified antibiotics, cholesterol medications, pain medications, over the counter medications such as TYLENOL, ADVIL, BENADRYL, cough syrups. The concomitant medications included SYNTHROID, atenolol and CRESTOR for unknown indications. The patient had no lab data. On 31-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). On 02-Feb-2018, after 2 days of vaccination, the patient developed a low-grade fever of temperature varying from 97.5 to 97.8. On the same day, the patient also experienced burning, aching pain in arm that spread to back between shoulder blades, left upper arm and across chest. The patient experienced fatigue, burning eyes, headache. The patient slept on chair because the pain did not allow to lie down. The pain was unbearable, hard to explain, burned, aches and hurt. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Peripheral swelling, Swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736223), concerns a 65-year-old, elderly female patient. The patient had no medical history, current illness and lab data. The patient's current condition included, aspirin allergy. The concomitant medications included unspecified vitamins for hair, skin and nail. On 02-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178303, expiry date: not reported) and PREVNAR 13 (route of administration: intramuscular, anatomical location: left arm, batch number: S92740 (as reported), dose, expiry date: not reported). On the same day, after the vaccination, the patient experienced swelling of left superior arm, left armpit and left side of the chest. On an unspecified date, the patient was recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received 07-Apr-2018: The sentence in the narrative and case comment was corrected from (the patient experienced left superior arm) to (the patient experienced swelling of left superior arm).
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site swelling, Oedema peripheral, Swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736223), concerns a 65-year-old, elderly female patient. The patient had no medical history, current illness and lab data. The patient's current condition included, aspirin allergy. The concomitant medications included unspecified vitamins for hair, skin and nail. On 02-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178303, expiry date: not reported) and PREVNAR 13 (route of administration: intramuscular, anatomical location: left arm, batch number: S92740 (as reported), dose, expiry date: not reported). On the same day, after the vaccination, the patient experienced swelling of left superior arm, left armpit and left side of the chest. On an unspecified date, the patient was recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received 07-Apr-2018: The sentence in the narrative and case comment was corrected from (the patient experienced left superior arm) to (the patient experienced swelling of left superior arm).
Age: 72.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736253), concerns a 72-year-old, elderly, female patient. The patient's historical conditions, allergies, current illness and concomitant medications were not reported. On 12-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179303 and expiry date: not reported). On the same day, after the vaccination, the patient experienced a sore arm and pain in joint. It was reported that, after two weeks of vaccination, the patient still experienced the events. At the time of this report, the outcome of the events was not recovered. The reporter assessed the events as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: Arthralgia, Asthenia, Cough, Dyspnoea, Headache
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736485), concerns a 65-year-old elderly male patient. The patient historical drug included unspecified flu vaccine and experienced injection site pain. The patient's current condition included nasal congestion (since an unspecified date) and allergic to tetracycline. The patient's concomitant medications included LIPITOR and Ubiquinol. On 05-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day after vaccination, the patient experienced pain at the site of injection. On 06-Feb-2018 (next morning), the patient experienced weakness, headache (reported as slightly), muscle, joint pain and shortness of breath, when the patient tried to inhale deeply, resulted in dry cough. All the symptoms started since injection. At the time of this report, the patient was recovering from the events. The reporter assessed this case as non-serious. Non-significant case correction received 07-Apr-2018: The narrative statement was corrected from "which the patient tried to inhale deeply results in dry cough" to "when the patient tried to inhale deeply resulted in dry cough".
Age: 65.0
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: Injection site pain, Myalgia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736485), concerns a 65-year-old elderly male patient. The patient historical drug included unspecified flu vaccine and experienced injection site pain. The patient's current condition included nasal congestion (since an unspecified date) and allergic to tetracycline. The patient's concomitant medications included LIPITOR and Ubiquinol. On 05-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day after vaccination, the patient experienced pain at the site of injection. On 06-Feb-2018 (next morning), the patient experienced weakness, headache (reported as slightly), muscle, joint pain and shortness of breath, when the patient tried to inhale deeply, resulted in dry cough. All the symptoms started since injection. At the time of this report, the patient was recovering from the events. The reporter assessed this case as non-serious. Non-significant case correction received 07-Apr-2018: The narrative statement was corrected from "which the patient tried to inhale deeply results in dry cough" to "when the patient tried to inhale deeply resulted in dry cough".
Age: 68.0
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: Dizziness, Rash
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736840), concerns a 68-year-old, elderly male patient. The patient's current condition included epilepsy. The concomitant medications included lamotrigine, carvedilol and divalproex. On 02-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number: 179101, expiry date: not reported). On the same day, approximately after 5 minutes of vaccination, the patient experienced rash on the left hand and wrist. The patient also felt dizziness. After 1 hour of vaccination, the patient reported that, rash remained the same but there was a slight improvement in dizziness. The patient had no other symptoms. At the time of this report, the patient had not recovered from the event rash, while the event dizziness was recovering. The reporter assessed the case as non-serious.
Age: 81.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Immediate post-injection reaction, Injection site pain, Pain
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 736961), concerns an 81-year-old elderly female patient. The patient's historical vaccines included diphtheria and tetanus which lead to allergy. The patient was also allergic to sulfa. The patient's concomitant medications included Enalapril, atorvastatin, oxycodone/APAP, lorazepam, CIPRO, metronidazole all for an unknown indication. On 23-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179601). On the same day, after vaccination, the patient experienced severe pain in arm at the injection site, especially upon movement of arm. It was reported that the pain started immediately after the vaccination. The patient reported that, the injection site appeared fine and there was no swelling and redness. At the time of report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 70.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site pain, Injection site swelling, Local reaction
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 737365), concerns a 70-year-old elderly, female patient. The patient's medical history and concomitant medications were not reported. On 01-Feb-2018, FLUAD (TIV) (batch number: 178903, expiry date: 31-May-2018, dose, route of administration, anatomical location: not reported) and PREVNAR 13 (batch number: 574424 (as reported), expiry date: Dec-2019, dose, route of administration, anatomical location: not reported). On the same day, after vaccination the patient developed local reactions/side effects including piercing pain and swelling at the site of injection. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 70.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Axillary mass, Tenderness
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 737404), concerns a 70-year-old, elderly, female patient. The patient's historical conditions, allergies, current illness and concomitant medications were not reported. On 12-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179003 and expiry date: not reported). On the same day, after the vaccination, the patient experienced a lump in the left axillary region and tender sensation along left side of neck. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 75.0
Sex: M
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: This initial spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (regulatory reference number: 737429), concerning a 75-year-old, elderly patient of unspecified gender. The patient had no medical history and current illness. On 05-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as unk), route of administration: intramuscular, anatomical location: right arm, batch number: 179601 and expiry date: not reported). On the same day, the patient was also administered with PREVNAR 13 (route of administration: intramuscular, anatomical location: left arm, batch number: T0848, dose and expiry date: not reported). On 12-Feb-2018, 07 days after the vaccination, the patient developed redness, lump and itching at the site of injection. Outcome of the events was reported as unknown. The reporter considered the case as non-serious.
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 737511), concerns a patient of unspecified age and gender. The patient's medical history and concomitant medications were not reported. On 30-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5ml (unk as reported), route of administration: intramuscular, anatomical location: left arm, batch n umber: 179501). On 01-Feb-2018, 2 days after vaccination, the patient experienced muscle pain at injection site. The patient called to the pharmacy on 13-Feb-2018 and reported the event. At the time of report, the patient had not yet recovered from the event. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Back pain, Coordination abnormal, Hypoaesthesia, Muscular weakness, Musculoskeletal pain
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 737545), concerns a 67-year-old elderly female patient. The patient's historical conditions included mouth pain off and on from dental bridges and neuropathy in toes. The patient's concomitant medications included Supplements-B complex, CATAPLEX D, Boswellia, omega, CATAPLEX A C P, probiotic, BIODENT, lorazepam for an unknown indication. On 30-Jan-2018, the patient was administered with FLUAD (TIV) dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179603). On 31-Jan-2018, one day after vaccination, at 4:30 am in the morning, the patient experienced severe vertigo, trouble with coordination and leg weakness. On the following day (01-Feb-2018), the patient had pain in lower back, arm and shoulder. Additionally, buzzing in head which continued. It was reported that, shoulder pain, weakness in legs have not subsided, weakness in legs was ongoing. Since the time of vaccination, the patient's toes were numb (reported as more numb) which continued. The patient consulted her family doctor to report the symptoms from the flu vaccine. It was stated that, two weeks and one day later, the patient yet experienced shoulder pain and arm pain. The patient experienced worsening of the events (shoulder pain, leg weakness and aching in legs). The patient took lot of water and ate healthy food hoping it would help but the events had not resolved. At the time of report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Pain in extremity, Tinnitus, Vertigo
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 737545), concerns a 67-year-old elderly female patient. The patient's historical conditions included mouth pain off and on from dental bridges and neuropathy in toes. The patient's concomitant medications included Supplements-B complex, CATAPLEX D, Boswellia, omega, CATAPLEX A C P, probiotic, BIODENT, lorazepam for an unknown indication. On 30-Jan-2018, the patient was administered with FLUAD (TIV) dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179603). On 31-Jan-2018, one day after vaccination, at 4:30 am in the morning, the patient experienced severe vertigo, trouble with coordination and leg weakness. On the following day (01-Feb-2018), the patient had pain in lower back, arm and shoulder. Additionally, buzzing in head which continued. It was reported that, shoulder pain, weakness in legs have not subsided, weakness in legs was ongoing. Since the time of vaccination, the patient's toes were numb (reported as more numb) which continued. The patient consulted her family doctor to report the symptoms from the flu vaccine. It was stated that, two weeks and one day later, the patient yet experienced shoulder pain and arm pain. The patient experienced worsening of the events (shoulder pain, leg weakness and aching in legs). The patient took lot of water and ate healthy food hoping it would help but the events had not resolved. At the time of report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Mobility decreased, Pain, Swelling
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 737823), concerns a 75-year-old, elderly, female patient. The patient's historical condition and concomitant medications were not reported. The patient had no current illness. The patient had been allergic to sulpha drugs. On 02-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml [reported as 1], anatomical location: left arm, batch number: 179101, route of administration: unknown and expiry date: not reported. It was reported that, injection was given too high in arm. On the same day, after vaccination, the patient experienced pain (unspecified), shoulder swelling and reduce mobility. No lab investigations were performed. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the events as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Mobility decreased, Pain, Product administered at inappropriate site, Swelling
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 737823), concerns a 75-year-old, elderly, female patient. The patient's historical condition and concomitant medications were not reported. The patient had no current illness. The patient had been allergic to sulpha drugs. On 02-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml [reported as 1], anatomical location: left arm, batch number: 179101, route of administration: unknown and expiry date: not reported. It was reported that, injection was given too high in arm. On the same day, after vaccination, the patient experienced pain (unspecified), shoulder swelling and reduce mobility. No lab investigations were performed. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the events as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Injection site pain, Joint range of motion decreased, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738530), concerns a 72-year-old, elderly, female patient. The patient had no historical condition, current illness and allergies. The patient's concomitant medications were not reported. On 12-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml [reported as 1], route of administration: intramuscular, anatomical location: left arm, batch number: 178602 and expiry date: not reported). 13-Sep-2017, after 1 day of vaccination, the patient experienced pain in left arm, which hurt on laying during sleep. The patient also had lost some range of motion and pain had not been subsided. On 21-Feb-2018, the patient went to the pharmacist, who recommended her OTC (over the counter drug), ibuprofen or ALEVE for some relief and use of an ice pack. The patient had not contacted her doctor. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Joint range of motion decreased, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738530), concerns a 72-year-old, elderly, female patient. The patient had no historical condition, current illness and allergies. The patient's concomitant medications were not reported. On 12-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml [reported as 1], route of administration: intramuscular, anatomical location: left arm, batch number: 178602 and expiry date: not reported). 13-Sep-2017, after 1 day of vaccination, the patient experienced pain in left arm, which hurt on laying during sleep. The patient also had lost some range of motion and pain had not been subsided. On 21-Feb-2018, the patient went to the pharmacist, who recommended her OTC (over the counter drug), ibuprofen or ALEVE for some relief and use of an ice pack. The patient had not contacted her doctor. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 19.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Medication error, No adverse event
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738641), concerns a 19-year-old, adult, female patient. The patient had no historical, current condition and no new drug allergy (NKDA). The patient did not receive any concomitant medication. On 15-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179202 and expiry date: not reported) instead of the regular influenza vaccine (medication error). On 22-Feb-2018, on follow up, patient notified the error and stated that, she was fine with no problems. No lab investigations were performed. It was reported that, patient did not experience any adverse event after the vaccination. The reporter assessed the event as non-serious.
Age: 19.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738641), concerns a 19-year-old, adult, female patient. The patient had no historical, current condition and no new drug allergy (NKDA). The patient did not receive any concomitant medication. On 15-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179202 and expiry date: not reported) instead of the regular influenza vaccine (medication error). On 22-Feb-2018, on follow up, patient notified the error and stated that, she was fine with no problems. No lab investigations were performed. It was reported that, patient did not experience any adverse event after the vaccination. The reporter assessed the event as non-serious.
Age: 78.0
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738642), concerns a 78-year-old, elderly, male patient. The patient's historical vaccine included flu shot. The patient's historical, current condition, allergies and concomitant medications were unknown. On 17-Feb-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179501 and expiry date: not reported) instead of pneumonia shot, due to miscommunication (wrong vaccine administered). It was reported that, patient did not experience any adverse event after the vaccination. The reporter assessed the event as non-serious.
Age: 79.0
Sex: F
Vaccine: FLU4, FLUA3
Symptoms: Abdominal pain upper, Computerised tomogram abdomen normal, Computerised tomogram pelvis, Erythema, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professionals to VAERS and initially retrieved on 19-May-2018 by Seqirus from VAERS (VAERS ID: 738890), concerning a 79-year-old, elderly, female patient. The patient's current condition included: Asthmatic and hypertension. The patient was allergic to tetanus toxoid. Concomitant medications included: Diltiazem, Bayer aspirin, CENTRUM SILVER, B complex, Vitamin D3, Fish oil and Hydrochlorothiazide for an unknown indication. On 11-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), anatomical location: left arm, batch number: 178903, route of administration, expiry date: not reported). On 12-Dec-2017, after one day of vaccination, the patient developed spot that turned red and swelling of arms. In addition, the patient also experienced swelling of upper chest under breast and stomach. A lot pain in arm. It was reported that, the patient still experienced swelling and hurt (ongoing at 4 weeks as of now). On 14-Dec-2017, the patient underwent computed tomography (CT) of abdomen and pelvis was performed due to right upper quadrant pain which was found to be normal. On 16-Dec-2017, the patient visited emergency department. On the same day, CT showed no evidence for acute cholecystitis, ultrasound was performed which showed no reaction was from the flu shot. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 79.0
Sex: F
Vaccine: FLU4, FLUA3
Symptoms: Peripheral swelling, Swelling, Ultrasound scan normal
Clinical narrative: This spontaneous case, reported by other health professionals to VAERS and initially retrieved on 19-May-2018 by Seqirus from VAERS (VAERS ID: 738890), concerning a 79-year-old, elderly, female patient. The patient's current condition included: Asthmatic and hypertension. The patient was allergic to tetanus toxoid. Concomitant medications included: Diltiazem, Bayer aspirin, CENTRUM SILVER, B complex, Vitamin D3, Fish oil and Hydrochlorothiazide for an unknown indication. On 11-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), anatomical location: left arm, batch number: 178903, route of administration, expiry date: not reported). On 12-Dec-2017, after one day of vaccination, the patient developed spot that turned red and swelling of arms. In addition, the patient also experienced swelling of upper chest under breast and stomach. A lot pain in arm. It was reported that, the patient still experienced swelling and hurt (ongoing at 4 weeks as of now). On 14-Dec-2017, the patient underwent computed tomography (CT) of abdomen and pelvis was performed due to right upper quadrant pain which was found to be normal. On 16-Dec-2017, the patient visited emergency department. On the same day, CT showed no evidence for acute cholecystitis, ultrasound was performed which showed no reaction was from the flu shot. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Headache, Injection site inflammation, Injection site pain, Injection site pruritus
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 738926), concerns a 67-year-old, elderly, female patient. The patient's historical and current conditions were not reported. The patient had been allergic to erythromycin. The patient's concomitant medication included Levothyroxine for an unknown indication. On 16-Feb-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml [reported as 1], anatomical location: right arm, batch number: 178503, route of administration: unknown and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose: 1 DF, anatomical location; left arm, batch number: S92741, route of administration: unknown and expiry date: not reported). On the same day, after vaccination, the patient experienced headache and soreness, itchiness, inflammation from injection site to elbow in left arm. The patient received ice therapy and ADVIL which reduce her events. On an unspecified date, the patient had completely recovered from the events. The reporter assessed the events as non-serious.
Age: 74.0
Sex: M
Vaccine: FLUA3, FLUA3
Symptoms: Burning sensation, Inflammation, Paraesthesia
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-May-2018 by Seqirus from VAERS (VAERS ID: 740489), concerns a 74-year-old, elderly, male patient. The patient's historical conditions, current conditions, allergies and concomitant medications were not reported. On 21-Feb-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml [reported as 1], route of administration: intramuscular, anatomical location: left arm, batch number: 179303 and expiry date: not reported). On 23-Feb-2018, after 2 days of vaccination, the patient experienced tingling sensation in both hands, burning and inflammation sensation. No swelling or redness were reported. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Neuralgia
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of pain localized in a male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced pain localized and activities of daily living impaired. On an unknown date, the outcome of the pain localized and activities of daily living impaired were unknown. It was unknown if the reporter considered the pain localized and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had the first SHINGRIX shot about 3 weeks ago.  The next day the patient started getting the same pain on right side that had when had shingles 4 years ago. It had increased in intensity over time. It was completely disrupted the patient's life because the pain was so intense.
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Post herpetic neuralgia
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of pain localized in a male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced pain localized and activities of daily living impaired. On an unknown date, the outcome of the pain localized and activities of daily living impaired were unknown. It was unknown if the reporter considered the pain localized and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had the first SHINGRIX shot about 3 weeks ago.  The next day the patient started getting the same pain on right side that had when had shingles 4 years ago. It had increased in intensity over time. It was completely disrupted the patient's life because the pain was so intense.
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Loss of personal independence in daily activities, Pain
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of pain localized in a male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced pain localized and activities of daily living impaired. On an unknown date, the outcome of the pain localized and activities of daily living impaired were unknown. It was unknown if the reporter considered the pain localized and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had the first SHINGRIX shot about 3 weeks ago.  The next day the patient started getting the same pain on right side that had when had shingles 4 years ago. It had increased in intensity over time. It was completely disrupted the patient's life because the pain was so intense.
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Asthenia, Condition aggravated, Decreased activity, Neuralgia, Pain
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of pain localized in a male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced pain localized and activities of daily living impaired. On an unknown date, the outcome of the pain localized and activities of daily living impaired were unknown. It was unknown if the reporter considered the pain localized and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had the first SHINGRIX shot about 3 weeks ago.  The next day the patient started getting the same pain on right side that had when had shingles 4 years ago. It had increased in intensity over time. It was completely disrupted the patient's life because the pain was so intense.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Angiogram cerebral, Computerised tomogram head, Culture, Encephalopathy, Injection site reaction
Clinical narrative: Shivering, arm sore for two weeks, severe headache (like axe was taken to it), nausea, I passed out, lost control of my bladder. I was on field trip with my coworkers when this happened. They said my sentences weren't making sense. This was midday, and also the day after the shot. I work a fish hatchery, and live there also. When we got back to the hatchery, my daughter took me to the emergency room. Because I lost consciousness, and wasn't making sense, they did a Cat scan.  They discovered an anuerysm. Because the shot made really sick, fever and infection, I spent Tuesday night through Friday early afternoon in the hospital. I was on antibiotics the whole time. I was able to walk good by this time, so they released me. They did give me oral antibiotics for the next 10 days.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Myositis, Nuclear magnetic resonance imaging, Syncope
Clinical narrative: Shivering, arm sore for two weeks, severe headache (like axe was taken to it), nausea, I passed out, lost control of my bladder. I was on field trip with my coworkers when this happened. They said my sentences weren't making sense. This was midday, and also the day after the shot. I work a fish hatchery, and live there also. When we got back to the hatchery, my daughter took me to the emergency room. Because I lost consciousness, and wasn't making sense, they did a Cat scan.  They discovered an anuerysm. Because the shot made really sick, fever and infection, I spent Tuesday night through Friday early afternoon in the hospital. I was on antibiotics the whole time. I was able to walk good by this time, so they released me. They did give me oral antibiotics for the next 10 days.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Aneurysm, Chills, Computerised tomogram abnormal, Headache, Infection
Clinical narrative: Shivering, arm sore for two weeks, severe headache (like axe was taken to it), nausea, I passed out, lost control of my bladder. I was on field trip with my coworkers when this happened. They said my sentences weren't making sense. This was midday, and also the day after the shot. I work a fish hatchery, and live there also. When we got back to the hatchery, my daughter took me to the emergency room. Because I lost consciousness, and wasn't making sense, they did a Cat scan.  They discovered an anuerysm. Because the shot made really sick, fever and infection, I spent Tuesday night through Friday early afternoon in the hospital. I was on antibiotics the whole time. I was able to walk good by this time, so they released me. They did give me oral antibiotics for the next 10 days.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Loss of consciousness, Malaise, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Shivering, arm sore for two weeks, severe headache (like axe was taken to it), nausea, I passed out, lost control of my bladder. I was on field trip with my coworkers when this happened. They said my sentences weren't making sense. This was midday, and also the day after the shot. I work a fish hatchery, and live there also. When we got back to the hatchery, my daughter took me to the emergency room. Because I lost consciousness, and wasn't making sense, they did a Cat scan.  They discovered an anuerysm. Because the shot made really sick, fever and infection, I spent Tuesday night through Friday early afternoon in the hospital. I was on antibiotics the whole time. I was able to walk good by this time, so they released me. They did give me oral antibiotics for the next 10 days.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Speech disorder, Urinary incontinence
Clinical narrative: Shivering, arm sore for two weeks, severe headache (like axe was taken to it), nausea, I passed out, lost control of my bladder. I was on field trip with my coworkers when this happened. They said my sentences weren't making sense. This was midday, and also the day after the shot. I work a fish hatchery, and live there also. When we got back to the hatchery, my daughter took me to the emergency room. Because I lost consciousness, and wasn't making sense, they did a Cat scan.  They discovered an anuerysm. Because the shot made really sick, fever and infection, I spent Tuesday night through Friday early afternoon in the hospital. I was on antibiotics the whole time. I was able to walk good by this time, so they released me. They did give me oral antibiotics for the next 10 days.